Melatonin ameliorates autoimmune encephalomyelitis through suppression of intercellular adhesion molecule-1.
- Author:
Jong Chul KANG
;
Meejung AHN
;
Yong Sik KIM
;
Changjong MOON
;
Yongduk LEE
;
Myung Bok WIE
;
Young Jae LEE
;
Taekyun SHIN
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
Melatonin;
experimental autoimmune encepha-lomyelitis;
intercellular adhesion molecule-1
- MeSH:
Animals;
Encephalomyelitis, Autoimmune, Experimental/*immunology/prevention & control;
Female;
Immunohistochemistry;
Intercellular Adhesion Molecule-1/analysis/*immunology;
Male;
Melatonin/administration & dosage/*physiology;
Rats;
Rats, Inbred Lew;
Spinal Cord/chemistry/pathology
- From:Journal of Veterinary Science
2001;2(2):85-89
- CountryRepublic of Korea
- Language:English
-
Abstract:
Melatonin (N-acetyl-5-methoxytryptamine), a pineal neurohormone, is a hydroxyl radical scavenger and antioxidant, and plays an important role in the immune system. We studied the effect of exogenous melatonin on the pathogenesis of experimental autoimmune encephalomyelitis (EAE). EAE was induced in Lewis rats by immunization with rat spinal cord homogenates. Subsequent oral administration of melatonin at 5 mg/kg significantly reduced the clinical severity of EAE paralysis compared with administration of the vehicle alone (p<0.01). Infiltration of ED1 macrophages and CD4 T cells into spinal cords occurred both in the absence and presence of melatonin treatment, but melatonin-treated rats had less spinal cord infiltration of inflammatory cells than did the control group. ICAM-1 immunoreactivity in the blood vessels of EAE lesions was decreased in melatonin-treated rats compared to vehicle-treated rats. These findings suggest that exogenous melatonin ameliorates EAE via a mechanism involving reduced expression of ICAM-1 and lymphocyte function associated antigen-1a in autoimmune target organs.
